Skip to main content

Table 1 Patients data

From: Surgical ablation for atrial fibrillation: impact of Diabetes Mellitus type 2

 

Group I (Non-DM)

Group II (DM)

p Value

N

484

122

 

Age

69 (62–75.3)

65 (57–72)

 < 0.001

Male gender (n, %)

259 (53.5%)

71 (58.2%)

0.362

Elective surgery (n, %)

437 (90.3%)

104 (85.2%)

0.182

NIHA III-IV (n, %)

179 (37%)

44 (36.1%)

0.454

Previous cardiac surgery (n, %)

40 (8.3%)

5 (4.1%)

0.127

EF (%)

60 (51.5–60)

60 (53–60)

0.618

LVEDD (cm)

5 (4.5–5.5)

5.1 (4.6–5.6)

0.136

Left atrial volume (cm3)

113 (81–151)

123 (93–163)

0.054

Left ventricular dysfunction

  Moderate (n, %)

19 (3.9%)

8 (6.6%)

0.651

  Severe (n, %)

6 (1.2%)

2 (1.6%)

Paroxysmal AF

279 (57.6%)

68 (55.7%)

0.376

Persistent AF

149 (30.8%)

45 (36.9%)

0.76

Long-standing and permanent AF

56 (11.6%)

9 (7.4%)

0.231

Arterial hypertension (n, %)

288 (59.5%)

104 (85.2%)

 < 0.001

COPD (n, %)

30 (6.2%)

14 (11.5%)

0.052

Dialysis (n, %)

1 (0.2%)

0 (0%)

1.000

Hyperlipidemia (n, %)

244 (50.4%)

92 (75.4%)

 < 0.001

PVD (n, %)

20 (4.1%)

6 (4.9%)

0.614

CVA/TIA (n, %)

46 (9.5%)

19 (15.6%)

0.048

Pulmonary hypertension (n, %)

90 (18.6%)

19 (15.6%)

0.509

HA1C (%)

6.5 (5.9–7.3)

5.6 (5.3–5.8)

 < 0.001

Standard EuroSCORE I

5 (4–7)

5 (3–6)

0.001

Logistic EuroSCORE I (%)

4.5 (2.7–8.1)

3.7 (2.1–5.8)

0.010